drug

Clonazepam

MeSH D002998

as of 2026-07-01

Add to landscape Monitor this Compare this Ask about this

at a glance

small molecule

Pre-approval / investigational in the US

Developed by Hannover Medical School

2 trials in the graph

Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality

small molecule

Indications

Investigational (via trials)

Schizophrenia Depression Psychosomatic Disorders Schizophreniform Disorder Schizophrenia Anxiety Disorders Depression Psychotic Disorders Psychophysiologic Disorders Dementia Anxiety Disorders Schizoaffective Disorder Dementia

Trials

Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia

NCT03061136Phase 4Withdrawn

Pharmacovigilance in Gerontopsychiatric Patients

NCT02374567Phase 3Terminated

KOLs & investigators

Helge Frieling, Prof., MDKOL score 5

Facts & assertions

0 sourced

No assertions recorded for this entity.

relationships

The graph out of here

developer

Hannover Medical School

company

trial

Clonazepam Effects on Brain Oscillations and Cognition in Schizophrenia

PHASE4

trial

Pharmacovigilance in Gerontopsychiatric Patients

PHASE3

trial

indication

Schizophrenia

indication

Depression

indication

Psychosomatic Disorders

indication

Schizophreniform Disorder

indication

KOL

Helge Frieling, Prof., MD

KOL score 5

person